Published on February 16, 2025, 02:01 PM UTC
Tags: human rights discrimination equality social justice activism
Hims & Hers (HIMS) stock plunged 26% on Tuesday despite a better-than-expected Q4 report, as investors worry about potential revenue loss from discontinued compounded weight-loss drugs. CFO Yemi Okupe downplayed these concerns, highlighting the company's diversified revenue stream and strong outlook for 2024, but Wall Street remains cautious amid industry-wide changes in semaglutide availability.
Published on: February 25, 2025, 05:01 PM UTC
Amazon's MGM Studios has taken creative control of the iconic James Bond film franchise, bolstering its streaming strategy amidst fierce competition from Netflix and Disney.
Published on: February 20, 2025, 06:02 PM UTC
Singapore's Abaxx Exchange to Launch Gold Futures Amid Soaring Prices and Demand for Safe Havens
Published on: February 20, 2025, 07:00 AM UTC
US stock futures edged higher after the S&P 500 hit a fresh record high in a late-session surge. Futures tracking the S&P 500, Dow Jones, and Nasdaq all gained, as investors await the release of the Fed's January meeting minutes and earnings reports from Etsy and Carvana.
Published on: February 19, 2025, 02:01 AM UTC
OpenAI rejects Elon Musk's $97.4 billion offer, calls it an attempt to "disrupt his competition." Musk, who sued OpenAI last year, leads a competing AI startup and recently purchased Twitter.
Published on: February 15, 2025, 02:00 AM UTC